Related Experiment Video

Updated: Feb 3, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K

The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in Multiple Myeloma

Jie Gu1, Sha Song2, Huiying Han2

  • 1Department of Haematology , The Second Affiliated Hospital of Soochow University , Suzhou , China.

Molecular Pharmaceutics
|October 20, 2018
PubMed

Insights

Combinatorial therapy with OTX015, a BET bromodomain inhibitor, shows enhanced efficacy against high-risk multiple myeloma (MM). Synergistic drug combinations improve antitumor activity and overcome treatment resistance in MM.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Treatment failure is a significant challenge in high-risk multiple myeloma (MM).
  • Combinatorial therapy offers a promising strategy to overcome drug resistance and off-target effects.
  • OTX015, a BET bromodomain inhibitor, shows preliminary activity but lacks sufficient efficacy as a monotherapy.

Purpose of the Study:

  • To investigate the synergistic potential of OTX015 in combination with other drugs for multiple myeloma treatment.
  • To elucidate the mechanisms by which OTX015 sensitizes myeloma cells to therapy.
  • To evaluate the antitumor activity of OTX015-based combinations in preclinical models.

Main Methods:

  • Preclinical evaluation of OTX015 in combination with three classes of drugs.
  • Assessment of synergistic drug combinations in mouse models of disseminated human myeloma.
  • Analysis of pathways and genes affected by OTX015 to understand sensitization mechanisms.

Main Results:

  • Synergistic drug combinations involving OTX015 demonstrated enhanced specificity compared to single-agent activity.
  • OTX015-based combinations significantly improved antitumor activity in myeloma mouse models.
  • OTX015 sensitized multiple myeloma cells by interrupting key proliferation and drug response pathways.

Conclusions:

  • Context-specific synergistic combinations with OTX015 offer improved therapeutic selectivity and control over complex biological systems in multiple myeloma.
  • These findings provide a strong rationale for combining OTX015 with conventional chemotherapeutic drugs for multiple myeloma therapy.
  • Targeting BET bromodomains with OTX015 in combination regimens holds promise for overcoming treatment resistance in high-risk multiple myeloma.
Keywords:
OTX015bromodomain inhibitormultiple myelomasynergism

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.5K
Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.7K

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
576
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.9K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
38.1K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
565
Multiple Regression01:25

Multiple Regression

Multiple regression assesses a linear relationship between one response or dependent variable and two or more independent variables. It has many practical applications.
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...
4.0K